Gamma-PN3

BIOLOGICAL2 trials

Sponsors

GPN Vaccines

Conditions

Pneumococcal Infections

Phase 1

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

CompletedNCT05667740

GPN VaccinesPneumococcal Infections

Start: 2023-01-16End: 2023-10-08Updated: 2024-09-05

Extension Safety and Immunogenicity Study of GPNV-001

CompletedNCT05982314

GPN VaccinesPneumococcal Infections

Start: 2023-07-17End: 2024-08-30Updated: 2024-12-18